A total of 32 patients treated with MDT for bone oligorecurrent disease had repeated PSMA-PET/CT examinations pre- and post-radiotherapy at the University Hospital Munich (LMU) between January 2015 and November 2022. This evidence concerns the gene FOLH1 and glycogen storage disease VI.